Potential Alzheimer’s Treatments in Growing Number of Phase 2 and Phase 3 Studies, Group Reports

Potential Alzheimer’s Treatments in Growing Number of Phase 2 and Phase 3 Studies, Group Reports
The number of clinical trials evaluating possible treatments for Alzheimer’s disease is on the increase, according to a recent analysis conducted by ResearchersAgainstAlzheimer’s (RA2), a global network of Alzheimer’s researchers that is part of a non-profit organization promoting the study and treatment of this disease, called UsAgainstAlzheimer’s. The results were recently presented at this year’s UsAgainstAlzheimer’s

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *